GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Envoy Medical Inc (NAS:COCH) » Definitions » EV-to-EBIT

Envoy Medical (Envoy Medical) EV-to-EBIT : -4.03 (As of May. 14, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Envoy Medical EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Envoy Medical's Enterprise Value is $58.87 Mil. Envoy Medical's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-14.60 Mil. Therefore, Envoy Medical's EV-to-EBIT for today is -4.03.

The historical rank and industry rank for Envoy Medical's EV-to-EBIT or its related term are showing as below:

COCH' s EV-to-EBIT Range Over the Past 10 Years
Min: -9.87   Med: -2.85   Max: -0.87
Current: -4.03

During the past 3 years, the highest EV-to-EBIT of Envoy Medical was -0.87. The lowest was -9.87. And the median was -2.85.

COCH's EV-to-EBIT is ranked worse than
100% of 456 companies
in the Medical Devices & Instruments industry
Industry Median: 20.465 vs COCH: -4.03

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Envoy Medical's Enterprise Value for the quarter that ended in Dec. 2023 was $31.83 Mil. Envoy Medical's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-14.60 Mil. Envoy Medical's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -45.87%.


Envoy Medical EV-to-EBIT Historical Data

The historical data trend for Envoy Medical's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Envoy Medical EV-to-EBIT Chart

Envoy Medical Annual Data
Trend Dec21 Dec22 Dec23
EV-to-EBIT
- - -1.73

Envoy Medical Quarterly Data
Dec21 Jun22 Sep22 Dec22 Jun23 Sep23 Dec23
EV-to-EBIT Get a 7-Day Free Trial - - - - -1.73

Competitive Comparison of Envoy Medical's EV-to-EBIT

For the Medical Devices subindustry, Envoy Medical's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Envoy Medical's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Envoy Medical's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Envoy Medical's EV-to-EBIT falls into.



Envoy Medical EV-to-EBIT Calculation

Envoy Medical's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=58.868/-14.6
=-4.03

Envoy Medical's current Enterprise Value is $58.87 Mil.
Envoy Medical's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-14.60 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Envoy Medical  (NAS:COCH) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Envoy Medical's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=-14.6/31.83176
=-45.87 %

Envoy Medical's Enterprise Value for the quarter that ended in Dec. 2023 was $31.83 Mil.
Envoy Medical's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-14.60 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Envoy Medical EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Envoy Medical's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Envoy Medical (Envoy Medical) Business Description

Traded in Other Exchanges
N/A
Address
4875 White Bear Parkway, White Bear Lake, MN, USA, 55110
Envoy Medical Inc is focused on designing, developing, and marketing fully implantable medical devices that improve hearing. The Company's first commercial product, the Esteem PMA application, is a fully implantable hearing device. The Esteem PMA was cleared in 2010 by the United States Food and Drug Administration. The Company intends to continue to pursue the development of a cochlear implant.